Citable filing context
ALGN's research view summarizes recent SEC filing context, starting with share_repurchase from Jul 29, 2026.
| Filed | Item | Context |
|---|---|---|
| Jul 29, 2026 | share_repurchase | Align Technology increased its 2026 share repurchase commitment to a total of $400 million to $500 million. |
| Jul 29, 2026 | earnings | Align Technology reported Q2 2026 revenue of $1.06 billion, a 4.3% increase year-over-year. |
| Jul 9, 2026 | management_change | Julie Coletti resigned as Executive Vice President, Chief Legal and Regulatory Officer, effective August 1, 2026. |
| Jul 29, 2026 | Guidance: clear_aligner_volume_growth | not reported to 6.00 |
| Jul 29, 2026 | Guidance: revenue | 1000.00 to 1020.00 |
| Jul 29, 2026 | Guidance: revenue_growth | 3.00 to 4.00 |
| Aug 5, 2026 | mda_quarterly | Align Technology (ALGN) reported second-quarter 2026 revenues of $1.06 billion, a 4.3% year-over-year increase, driven by an 8.2% rise in Clear Aligner revenue. While Clear Aligner case volume grew 7.4%, the Systems and Services segment—comprising iTero scanners and exocad software—declined 10.8% due to product mix shifts and lower scanner wand sales. Management highlighted significant macroeconomic headwinds, including inflation, high interest rates, and geopolitical instability, which have dampened consumer discretionary spending and contributed to four consecutive years of declining orthodontic starts. A notable trend is the shift toward traditional wires and brackets as doctors and patients navigate economic uncertainty. To support long-term growth, the company is investing $200 million in a new manufacturing facility in Hyderabad, India, expected to open in 2027. Financial results were impacted by a $37.5 million liability recorded following a UK tribunal ruling that subjects clear aligners to standard VAT. Despite these pressures, the company maintains a strong liquidity position with $1.1 billion in cash and equivalents. Capital allocation remains focused on a $1 billion share repurchase program, with $733 million remaining as of June 30, 2026. The company continues to prioritize operational efficiency, having completed a 2025 restructuring plan to right-size its workforce. |
| May 6, 2026 | mda_quarterly | Align Technology reported first-quarter 2026 revenues of $1.04 billion, a 6.2% year-over-year increase, driven primarily by a 7.4% rise in Clear Aligner revenues to $856 million. Systems and Services, including iTero scanners and exocad software, grew 0.9% to $184 million. Net income reached $113 million with an operating margin of 13.6%. Strategic growth focuses on international expansion, general practitioner adoption, and orthodontic utilization. However, macroeconomic pressures—including inflation, high interest rates, and tariff volatility—have dampened discretionary spending, causing some patients to shift from clear aligners to traditional wires and brackets. Geopolitical instability, specifically the February 2026 US-Iran conflict and tensions affecting iTero’s Israeli headquarters, remains a critical risk. To mitigate these headwinds, the company executed a 2025 restructuring plan costing $42 million to right-size its workforce. Financial flexibility is supported by $1.06 billion in cash and a $1 billion share repurchase program, with $800 million remaining. Projected 2026 capital expenditures are between $125 million and $150 million, focused on manufacturing capacity and technology upgrades. The company is also navigating a product mix shift toward lower average selling price configurations to meet evolving consumer budgets. |
Source: SEC EDGAR filing text and events; period Jul 29, 2026; filed Jul 29, 2026.
ALGN company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.